Capacity for identifying Janssen AD26.COV2.S COVID19 vaccination in four US health insurance and state immunization information system databases: Preparation for a post authorization safety study

Fuller, C. C.; Kawai, A. T.; Haynes, K.; Coughlin, K.; Reynolds, J.; Hawrusik, R.; Horgan, C.; Calingaert, B.; Johannes, C. B.; Layton, J. B.; Peterson, A.; Praet, N.; Willame, C.; Yost, E.; Brannan, C.; McMahill-Walraven, C. N.; Guzman, M.; Jamal-allial, A.; Nair, V.; Seals, R.; Wang, F.; Selvan, M.; Ma, Q. L.; Platt, R.; Gilsenan, A. W.; Brown, J.

Fuller, C. C.; Kawai, A. T.; Haynes, K.; Coughlin, K.; Reynolds, J.; Hawrusik, R.; Horgan, C.; Calingaert, B.; Johannes, C. B.; Layton, J. B.; Peterson, A.; Praet, N.; Willame, C.; Yost, E.; Brannan, C.; McMahill-Walraven, C. N.; Guzman, M.; Jamal-allial, A.; Nair, V.; Seals, R.; Wang, F.; Selvan, M.; Ma, Q. L.; Platt, R.; Gilsenan, A. W.; Brown, J..

Pharmacoepidemiology and Drug Safety ; 31:620-620, 2022.

Article in English | Web of Science | ID: covidwho-2083635

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Topics: Vaccines Language: English Journal: Pharmacoepidemiology and Drug Safety Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML